Profusa, Inc.

Profusa, Inc. (PFSA) is a digital health and medical device company developing implantable continuous biosensors designed to monitor real-time physiological markers from beneath the skin. The company filed a Form 10-Q with the Securities and Exchange Commission on October 9, 2024, providing a financial update for its most recent fiscal quarter. Profusa reached public markets through a SPAC merger and operates in the biotech and digital health sector. The quarterly report, bearing accession number 0001213900-24-086609, reflects the company's ongoing reporting obligations as a publicly traded entity. Sign up at SpacDesk for complete filing data, analytics, and historical records on PFSA.